Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.

<h4>Background</h4>Lung function abnormalities are ubiquitous in heart failure (HF). It is unclear, however, if abnormal lung diffusion capacity is associated with cardiac remodeling and antedates HF. We hypothesized that lower lung diffusion capacity for carbon monoxide (DLCO) is associ...

Full description

Bibliographic Details
Main Authors: Ibrahim Musa Yola, Albin Oh, Gary F Mitchell, George O'Connor, Susan Cheng, Ramachandran S Vasan, Vanessa Xanthakis
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0246355
_version_ 1818323579502067712
author Ibrahim Musa Yola
Albin Oh
Gary F Mitchell
George O'Connor
Susan Cheng
Ramachandran S Vasan
Vanessa Xanthakis
author_facet Ibrahim Musa Yola
Albin Oh
Gary F Mitchell
George O'Connor
Susan Cheng
Ramachandran S Vasan
Vanessa Xanthakis
author_sort Ibrahim Musa Yola
collection DOAJ
description <h4>Background</h4>Lung function abnormalities are ubiquitous in heart failure (HF). It is unclear, however, if abnormal lung diffusion capacity is associated with cardiac remodeling and antedates HF. We hypothesized that lower lung diffusion capacity for carbon monoxide (DLCO) is associated with worse left ventricular (LV) systolic and diastolic function cross-sectionally, and with higher risk of HF prospectively.<h4>Methods</h4>We evaluated 2423 Framingham Study participants (mean age 66 years, 55% women) free of HF who underwent routine echocardiography and pulmonary function tests. We used multivariable regression models to relate DLCO, forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1) to left ventricular ejection fraction (LVEF), left atrial (LA) emptying fraction (LAEF), E/e', E/A, LV mass, and LA diameter (LAD). Multivariable-adjusted Cox proportional hazards regression was used to relate DLCO, FEV1, and FVC to incident HF.<h4>Results</h4>In multivariable-adjusted cross-sectional analyses, DLCO, FEV1, and FVC (dependent variables) were associated positively with LVEF (βDLCO = 0.208, βFEV1 = 0.021, and βFVC = 0.025 per 5% increment in LVEF; p<0.005 for all), and LAEF (βDLCO = 0.707, βFEV1 = 0.058 and βFVC = 0.058 per 5% increment in LAEF; p<0.002 for all). DLCO and FVC were inversely related to E/A (βDLCO = -0.289, βFVC = -0.047 per SD increment in E/A; p<0.001 for all). Additionally, DLCO, FEV1 and FVC were inversely related to HF risk (108 events, median follow-up 9.7 years; multivariable-adjusted hazard ratios per SD increment 0.90, 95% CI 0.86-0.95; 0.42, 95% CI 0.28-0.65, and 0.51, 95% CI 0.36-0.73, respectively). These results remained robust in analyses restricted to non-smokers.<h4>Conclusions</h4>Our large community-based observations are consistent with the concept that lower lung diffusion capacity and expiratory flow rates are associated with cardiac remodeling and may antedate HF. Additional studies are needed to confirm our findings and to evaluate the prognostic utility of pulmonary function testing for predicting HF.
first_indexed 2024-12-13T11:14:56Z
format Article
id doaj.art-4d441c5c677447db85ef0911a060023b
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-13T11:14:56Z
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-4d441c5c677447db85ef0911a060023b2022-12-21T23:48:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01162e024635510.1371/journal.pone.0246355Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.Ibrahim Musa YolaAlbin OhGary F MitchellGeorge O'ConnorSusan ChengRamachandran S VasanVanessa Xanthakis<h4>Background</h4>Lung function abnormalities are ubiquitous in heart failure (HF). It is unclear, however, if abnormal lung diffusion capacity is associated with cardiac remodeling and antedates HF. We hypothesized that lower lung diffusion capacity for carbon monoxide (DLCO) is associated with worse left ventricular (LV) systolic and diastolic function cross-sectionally, and with higher risk of HF prospectively.<h4>Methods</h4>We evaluated 2423 Framingham Study participants (mean age 66 years, 55% women) free of HF who underwent routine echocardiography and pulmonary function tests. We used multivariable regression models to relate DLCO, forced vital capacity (FVC), and forced expiratory volume in 1 second (FEV1) to left ventricular ejection fraction (LVEF), left atrial (LA) emptying fraction (LAEF), E/e', E/A, LV mass, and LA diameter (LAD). Multivariable-adjusted Cox proportional hazards regression was used to relate DLCO, FEV1, and FVC to incident HF.<h4>Results</h4>In multivariable-adjusted cross-sectional analyses, DLCO, FEV1, and FVC (dependent variables) were associated positively with LVEF (βDLCO = 0.208, βFEV1 = 0.021, and βFVC = 0.025 per 5% increment in LVEF; p<0.005 for all), and LAEF (βDLCO = 0.707, βFEV1 = 0.058 and βFVC = 0.058 per 5% increment in LAEF; p<0.002 for all). DLCO and FVC were inversely related to E/A (βDLCO = -0.289, βFVC = -0.047 per SD increment in E/A; p<0.001 for all). Additionally, DLCO, FEV1 and FVC were inversely related to HF risk (108 events, median follow-up 9.7 years; multivariable-adjusted hazard ratios per SD increment 0.90, 95% CI 0.86-0.95; 0.42, 95% CI 0.28-0.65, and 0.51, 95% CI 0.36-0.73, respectively). These results remained robust in analyses restricted to non-smokers.<h4>Conclusions</h4>Our large community-based observations are consistent with the concept that lower lung diffusion capacity and expiratory flow rates are associated with cardiac remodeling and may antedate HF. Additional studies are needed to confirm our findings and to evaluate the prognostic utility of pulmonary function testing for predicting HF.https://doi.org/10.1371/journal.pone.0246355
spellingShingle Ibrahim Musa Yola
Albin Oh
Gary F Mitchell
George O'Connor
Susan Cheng
Ramachandran S Vasan
Vanessa Xanthakis
Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
PLoS ONE
title Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
title_full Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
title_fullStr Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
title_full_unstemmed Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
title_short Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
title_sort association of lung diffusion capacity with cardiac remodeling and risk of heart failure the framingham heart study
url https://doi.org/10.1371/journal.pone.0246355
work_keys_str_mv AT ibrahimmusayola associationoflungdiffusioncapacitywithcardiacremodelingandriskofheartfailuretheframinghamheartstudy
AT albinoh associationoflungdiffusioncapacitywithcardiacremodelingandriskofheartfailuretheframinghamheartstudy
AT garyfmitchell associationoflungdiffusioncapacitywithcardiacremodelingandriskofheartfailuretheframinghamheartstudy
AT georgeoconnor associationoflungdiffusioncapacitywithcardiacremodelingandriskofheartfailuretheframinghamheartstudy
AT susancheng associationoflungdiffusioncapacitywithcardiacremodelingandriskofheartfailuretheframinghamheartstudy
AT ramachandransvasan associationoflungdiffusioncapacitywithcardiacremodelingandriskofheartfailuretheframinghamheartstudy
AT vanessaxanthakis associationoflungdiffusioncapacitywithcardiacremodelingandriskofheartfailuretheframinghamheartstudy